Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Lynda Grine, EADV Spring Symposium 2021: Intermittent Fasting in Psoriasis

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 7th 2021

It was a pleasure to speak with Dr Lynda Grine (Ghent University Hospital, Ghent, Belgium) about her research into the effects of intermittent fasting on psoriasis.

Her presentation entitled ‘Interim results of the MANGO trial: effects of modified intermittent fasting in psoriasis’ was presented at the EADV Spring Symposium, 6-7 May 2021.

Questions

  1. Could you give us a brief overview of the comorbidities, including metabolic syndrome and leaky gut syndrome, associated with psoriasis? (0:05)
  2. What is the rationale for intermittent fasting in psoriasis patients? (1:19)
  3. Could you tell us a little about the MANGO trial protocol? (3:21)
  4. When will the results be available? (4:47)

Disclosures: Dr Lynda Grine has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.

Filmed as a highlight of EADV Spring 2021 (Virtual).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup